$0.948100
0.066.28%
At Close: -
$0.920000
-0.03-2.96%
After Hours: Aug 23, 6:21 PM EDT
15 minutes delayed
Lineage Cell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lineage Cell Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.03 | $-0.04 | 25.0 % |
Mar 2024 | 2024-05-09 | $-0.04 | $-0.04 | 0.00 % |
Dec 2023 | 2024-03-07 | $-0.03 | $-0.04 | 25.0 % |
Sep 2023 | 2023-11-09 | $-0.04 | $-0.04 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $1.41M | $970.00K | 45.1 % |
Mar 2024 | 2024-05-09 | $1.44M | $1.36M | 6.18 % |
Dec 2023 | 2024-03-07 | $2.10M | $1.31M | 60.3 % |
Sep 2023 | 2023-11-09 | $1.25M | $2.59M | -51.9 % |
Lineage Cell Therapeutics (LCTX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.03, which beat the estimate of $-0.04.
The Actual Revenue was $1.4M, which beat the estimate of $970K.
Browse earnings estimates, EPS, and revenue on all stocks.